About us
The Wales Applied Virology Unit launched on 1 April 2025 after receiving £3 million in funding from Health and Care Research Wales.
Aims
The Wales Applied Virology Unit (WAVU) aims to reduce the burden of viral disease through the development and evaluation of intervention and control strategies.
We intend to meet the needs of tomorrow’s patients through the delivery of next-generation advanced therapeutics, from enhanced vaccines to combat infectious disease and cancer, to engineered viral platforms for oncology and genome-editing applications.
This will be achieved using interdisciplinary expertise comprising basic and translational virology, clinical trials, public health epidemiology, and implementation science, to generate solutions in the field of viral disease, leading to more efficient research and improved care for patients and the public.
Research
Our research areas are:
Subscribe to our newsletter to hear the latest research news from the Wales Applied Virology Unit.
